阻断IL-6可以降低PD-L1的表达,并通过抑制STAT3信号通路来缓解肺纤维化
Xiao Hu1, Jie Tan1, Yujuan Wang2
1Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun 130041, China.
Cellular signalling
|July 23, 2025
概括
阻断INTERLEUKIN-6 (IL-6) 通过通过STAT3途径降低编程细胞死亡联体1 (PD-L1) 表达的调节,从而降低肺纤维化. 这为这种致命的肺病提供了新的治疗点.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 肺纤维化是一种致命的肺病,由于未知的发病因而治疗选择有限.
- 介乐-6 (IL-6) 和编程细胞死亡配体1 (PD-L1) 涉及到肺纤维化发展和纤维化.
- IL-6可能调节PD-L1的表达,这表明潜在的治疗联系.
研究的目的:
- 研究阻断IL-6对PD-L1表达的影响及其在肺纤维化中的作用.
- 阐明涉及STAT3信号通路的潜在机制.
主要方法:
- 已建立的小鼠肺纤维化模型使用白素 (BLM) 和用TGF-β1.1刺激人类胎儿肺纤维细胞 (HFL1s).
- 抑制IL-6信号传递或减少PD-L1表达.
- 分析了组织形态,蛋白质表达 (α-SMA,维丁,原I) 和纤维细胞功能.
主要成果:
- 在肺纤维化模型中观察到高IL-6和PD-L1表达.
- 阻断IL-6改善了肺组织损伤,减少了原沉积,并抑制了纤维化标记物 (α-SMA,Vimentin,原I).
- 通过IL-6抑制,通过STAT3抑制逆转TGF-β1诱导的纤维细胞转化为肌纤维细胞,随后降低PD-L1.1的调节.
结论:
- 准IL-6/STAT3信号有效降低PD-L1的表达,并减轻肺纤维化.
- 抑制PD-L1也显示出减少肺纤维化的潜力.
- IL-6和PD-L1代表了肺纤维化治疗的有希望的分子标.
相关概念视频
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K


